Pfizer Inc. is recalling 22,619 cartons of RELPAX (eletriptan HBr) 40 mg tablets because they may be contaminated with Burkholderia and Pseudomonas bacteria. The recall includes 6-count and 12-count cartons distributed across the United States and Puerto Rico. Consumers who have these migraine medications should check their packaging immediately for specific lot numbers and expiration dates. If you have the affected medicine, you should contact your healthcare provider or pharmacist for guidance on a replacement and return the product to your pharmacy for a refund.
The tablets may contain Burkholderia and Pseudomonas bacteria, which can cause serious, life-threatening infections in people with compromised immune systems or certain underlying health conditions. While no injuries have been reported, these bacteria can lead to pneumonia or blood infections if ingested or handled by vulnerable individuals.
Refund and Healthcare Consultation
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.